Characteristics of 9 patients with chronic lymphocytic leukemia who subsequently developed Kaposi sarcoma reported to the SEER Program, 1973-1996
| Case . | Age* . | Sex . | Race . | CLL (mo/y) . | KS (mo/y) . | Latency between CLL and KS (mo) . | KS site . | Survival after KS (mo) . | Cause of death . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 78 | M | White | 2/1976 | 3/1983 | 85 | R lower limb | 1 | CLL |
| 2 | 80 | M | White | 9/1980 | 8/1981 | 11 | Skin, NOS | 8 | Myocardial infarction |
| 3 | 67 | M | Black | 9/1983 | 12/1989 | 75 | Skin, NOS | 28 | CLL |
| 4 | 73 | F | White | 2/1978 | 9/1982 | 55 | L upper limb | 5 | CLL |
| 5 | 66 | F | White | 6/1980 | 12/1988 | 102 | B lower limbs | 17 | CLL |
| 6 | 66 | F | White | 6/1986 | 10/1994 | 100 | Skin, NOS | 26 | (Alive) |
| 7 | 91 | F | White | 11/1988 | 8/1989 | 9 | Skin, NOS | 2 | Myocardial infarction |
| 8 | 70 | F | White | 12/1988 | 11/1990 | 23 | Skin, NOS | 27 | CLL |
| 9 | 85 | F | White | 3/1995 | 5/1995 | 2 | B lower limb | 5 | KS |
| Case . | Age* . | Sex . | Race . | CLL (mo/y) . | KS (mo/y) . | Latency between CLL and KS (mo) . | KS site . | Survival after KS (mo) . | Cause of death . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 78 | M | White | 2/1976 | 3/1983 | 85 | R lower limb | 1 | CLL |
| 2 | 80 | M | White | 9/1980 | 8/1981 | 11 | Skin, NOS | 8 | Myocardial infarction |
| 3 | 67 | M | Black | 9/1983 | 12/1989 | 75 | Skin, NOS | 28 | CLL |
| 4 | 73 | F | White | 2/1978 | 9/1982 | 55 | L upper limb | 5 | CLL |
| 5 | 66 | F | White | 6/1980 | 12/1988 | 102 | B lower limbs | 17 | CLL |
| 6 | 66 | F | White | 6/1986 | 10/1994 | 100 | Skin, NOS | 26 | (Alive) |
| 7 | 91 | F | White | 11/1988 | 8/1989 | 9 | Skin, NOS | 2 | Myocardial infarction |
| 8 | 70 | F | White | 12/1988 | 11/1990 | 23 | Skin, NOS | 27 | CLL |
| 9 | 85 | F | White | 3/1995 | 5/1995 | 2 | B lower limb | 5 | KS |
CLL indicates chronic lymphocytic leukemia; KS, Kaposi sarcoma; SEER, Surveillance, Epidemiology, and End Results; R, right; L, left; B, bilateral; NOS, not otherwise specified.
Age at CLL diagnosis.